Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Increased serum neopterin levels in acutely ill and recovered schizophrenic patients.

Korte S, Arolt V, Peters M, Weitzsch C, Rothermundt M, Kirchner H.

Schizophr Res. 1998 Jun 22;32(1):63-7.

PMID:
9690336
2.

Is schizophrenia linked to alteration in cellular immunity?

Sperner-Unterweger B, Barnas C, Fleischhacker WW, Fuchs D, Meise U, Reibnegger G, Wachter H.

Schizophr Res. 1989 Jul-Oct;2(4-5):417-21.

PMID:
2487182
3.

Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity.

Sperner-Unterweger B, Barnas C, Fuchs D, Kemmler G, Wachter H, Hinterhuber H, Fleischhacker WW.

Psychiatry Res. 1992 May;42(2):121-8.

PMID:
1631249
4.

Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.

Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL.

Arch Gen Psychiatry. 1991 Jan;48(1):73-6.

PMID:
1670618
5.

Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study.

Chittiprol S, Venkatasubramanian G, Neelakantachar N, Babu SV, Reddy NA, Shetty KT, Gangadhar BN.

J Psychiatr Res. 2010 Apr;44(5):310-3. doi: 10.1016/j.jpsychires.2009.09.002.

PMID:
19850302
6.
7.

Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.

Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL.

Arch Gen Psychiatry. 1991 Oct;48(10):910-3.

PMID:
1929760
9.

Associative learning in acutely ill and recovered schizophrenic patients.

O'Carroll RE.

Schizophr Res. 1995 May;15(3):299-301.

PMID:
7632628
10.

Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders.

Kuehne LK, Reiber H, Bechter K, Hagberg L, Fuchs D.

J Psychiatr Res. 2013 Oct;47(10):1417-22. doi: 10.1016/j.jpsychires.2013.05.027.

PMID:
23790260
11.

Communication disturbances in schizophrenia: a two-process formulation.

Docherty NM.

Compr Psychiatry. 1995 May-Jun;36(3):182-6.

PMID:
7648840
12.

Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.

Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.

Psychiatry Res. 2009 Jul 30;168(2):110-8. doi: 10.1016/j.psychres.2008.04.011.

PMID:
19501918
13.

Relationship of serum haloperidol levels to clinical response in schizophrenic patients.

Magliozzi JR, Hollister LE, Arnold KV, Earle GM.

Am J Psychiatry. 1981 Mar;138(3):365-7.

PMID:
7468835
14.
15.

Neopterin and biopterin CSF levels in tardive dyskinesia after clozapine treatment.

Fleischhacker WW, Levine RA, Lieberman JA, Pollack S, Johns CA, Richardson MA.

Biol Psychiatry. 1993 Nov 15;34(10):741-5. No abstract available.

PMID:
8292676
16.

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.

Kramer MS, Last B, Getson A, Reines SA.

Arch Gen Psychiatry. 1997 Jun;54(6):567-72. Erratum in: Arch Gen Psychiatry 1997 Dec;54(12):1080.

PMID:
9193198
17.

Neopterin and macrophage inflammatory protein-1alpha in the cerebrospinal fluid of schizophrenic patients: no evidence of intrathecal inflammation.

Nikkilä HV, Ahokas A, Wahlbeck K, Rimón R, Andersson LC.

Neuropsychobiology. 2002;46(4):169-72.

PMID:
12566931
18.

Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.

Keks NA, Copolov DL, Kulkarni J, Mackie B, Singh BS, McGorry P, Rubin RT, Hassett A, McLaughlin M, van Riel R.

Biol Psychiatry. 1990 Jun 1;27(11):1203-15.

PMID:
2354227
19.

Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC.

Schizophr Res. 2002 Oct 1;57(2-3):247-58. Erratum in: Schizophr Res. 2003 Mar 1;60(1):101..

PMID:
12223256
20.

The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.

Zhang XY, Chen DC, Xiu MH, Wang F, Qi LY, Sun HQ, Chen S, He SC, Wu GY, Haile CN, Kosten TA, Lu L, Kosten TR.

Schizophr Res. 2009 Sep;113(2-3):151-7. doi: 10.1016/j.schres.2009.05.016.

PMID:
19540723

Supplemental Content

Support Center